Robert Matusik, Ph.D.


Selected Publications

  • Oottamasathien S, Wang Y, Williams K, Franco OE, Wills ML, Thomas JC, Saba K, Sharif-Afshar AR, Makari JH, Bhowmick NA, DeMarco RT, Hipkens S, Magnuson M, Brock JW, Hayward SW, Pope JC, Matusik RJ. Directed differentiation of embryonic stem cells into bladder tissue. Dev. Biol [print-electronic]. 2007 Apr 4/15/2007; 304(2): 556-66. PMID: 17289017, PMCID: PMC1994155, PII: S0012-1606(07)00027-9, DOI: 10.1016/j.ydbio.2007.01.010, ISSN: 0012-1606.
  • Suzuki K, Yu X, Chaurand P, Araki Y, Lareyre JJ, Caprioli RM, Orgebin-Crist MC, Matusik RJ. Epididymis-specific lipocalin promoters. Asian J. Androl. 2007 Jul; 9(4): 515-21. PMID: 17589789, DOI: 10.1111/j.1745-7262.2007.00300.x, ISSN: 1008-682X.
  • Barrios R, Lebovitz RM, Wiseman AL, Weisoly DL, Matusik RJ, DeMayo F and Lieberman MW. Ras T24 driven by a probasin promoter induces prostatic hyperplasia in transgenic mice. Transgenics. 1996; 2: 23-8.
  • Leonard MP, Sareen S, Hills K, Sheppard PC and Matusik RJ. Early characterization of a novel metastatic disease model of murine neuroblastoma. J. of Urol. 1996; 1565: 696-700.
  • Snoek R, Rennie PS, Kasper S, Matusik RJ, Bruchovsky N. Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides. J. Steroid Biochem. Mol. Biol. 1996 Nov; 59(3-4): 243-50. PMID: 9010316, PII: S0960-0760(96)00116-1, ISSN: 0960-0760.
  • Levy I, Matusik RJ, Dodd J, Gallagher R and Meyer F. Joint workshop on laboratory aspects of proposed national prostate cancer screening trial: Part II. The establishment of a biorepository (Laboratory Centre for Disease Control, Health Canada). Chronic Diseases of Canada. 1995; 16: 129-30.
  • Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U.S.A. 1995 Apr 4/11/1995; 92(8): 3439-43. PMID: 7724580, PMCID: PMC42182, ISSN: 0027-8424.
  • Dubé JY, Chapdelaine P, Guérin S, Leclerc S, Rennie PS, Matusik RJ, Tremblay RR. Search for androgen response elements in the proximal promoter of the canine prostate arginine esterase gene. J. Androl. 1995 Jul; 16(4): 304-11. PMID: 8537247, ISSN: 0196-3635.
  • Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Dodd JG, Duckworth ML, Rosen RJ and Matusik R. The rat probasin gene promoter directs hormonally-and developmentally-regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Molecular Endocrinology. 1994; 8: 230-9.
  • Kasper S, Rennie PS, Bruchovsky N, Sheppard PC, Cheng H, Lin L, Shin RPC, Snoek R and Matusik RJ. Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J. of Biol. Chem. 1994; 269: 31763-9.
  • Dedhar S, Rennie PS, Shago M, Hagesteijn CY, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ. Inhibition of nuclear hormone receptor activity by calreticulin. Nature. 1994 Feb 2/3/1994; 367(6462): 480-3. PMID: 8107809, DOI: 10.1038/367480a0, ISSN: 0028-0836.
  • Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Block ME, MacDonald BS Nickel BE, Chang C, Liao, S, Cattini PA and Matusik RJ. Characterization of two cis-acting elements involved in the androgen regulation of the probasin gene. Molecular Endocrinology. 1993; 7: 23-36.
  • Kazemi-Esfajani P, Beitel L, Trifiro M, Kaufman M, Rennie PS, Sheppard P, Matusik RJ, and Pinsky L. Substitution of valine 865 by methionine or leucine causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotype. Molecular Endocrinology. 1993; 7: 37-46.